Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15261, USA.
Cytotherapy. 2012 Apr;14(4):494-504. doi: 10.3109/14653249.2011.651529. Epub 2012 Jan 23.
The immunomodulatory and anti-inflammatory effects of mesenchymal stromal cells (MSC) could prove to be a potential therapeutic approach for prolongation of survival of cell xenotransplantation. Adipose (Ad) MSC from genetically modified pigs could be an abundant source of pig donor-specific MSC.
Pig (p) MSC were isolated from adipose tissue of α1,3-galactosyltransferase gene knock-out pigs transgenic for human (h) CD46 (GTKO/hCD46), a potential source of islets. After characterization with differentiation and flow cytometry (FCM), AdMSC were compared with bone marrow (BM) MSC of the same pig and human adipose-derived (hAd) MSC. The modulation of human peripheral blood mononuclear cell (hPBMC) responses to GTKO pig aortic endothelial cells (pAEC) by different MSC was compared by measuring 3H-thymidine uptake. The supernatants from the AdMSC cultures were used to determine the role of soluble factors.
GTKO/hCD46 pAdMSC (i) did not express galactose-α1,3-galactose (Gal) but expressed hCD46, (ii) differentiated into chondroblasts, osteocytes and adipocytes, (iii) expressed stem cell markers, (iv) expressed lower levels of Swine Leucocyte Antigen I (SLAI), Swine Leucocyte Antigen II DR (SLAIIDR) and CD80 than pAEC before and after pig interferon (IFN)-γ stimulation. The proliferative responses of hPBMC to GTKO/hCD46 pAdMSC and hAdMSC stimulators were similar, and both were significantly lower than to GTKO pAEC (P < 0.05). The proliferation of hPBMC to GTKO pAEC was equally suppressed by GTKO/hCD46 pAdMSC and hAdMSC (P > 0.05). The supernatant from GTKO/hCD46 pAdMSC did not suppress the human xenoresponse to GTKO pAEC, which was cell-cell contact-dependent.
Initial evidence suggests that genetically modified pAdMSC function across the xenogeneic barrier and may have a role in cellular xenotransplantation.
间充质基质细胞(MSC)的免疫调节和抗炎作用可能被证明是延长细胞异种移植存活的潜在治疗方法。来自基因修饰猪的脂肪(Ad)MSC 可以成为猪供体特异性 MSC 的丰富来源。
从基因敲除猪的脂肪组织中分离出 MSC,这些猪转基因表达人(h)CD46(GTKO/hCD46),这是胰岛的潜在来源。通过分化和流式细胞术(FCM)进行特征描述后,将 AdMSC 与来自同一头猪和人脂肪来源(hAd)MSC 的骨髓(BM)MSC 进行比较。通过测量 3H-胸腺嘧啶摄取来比较不同 MSC 对 GTKO 猪主动脉内皮细胞(pAEC)的人外周血单个核细胞(hPBMC)反应的调节作用。使用 AdMSC 培养物的上清液来确定可溶性因子的作用。
GTKO/hCD46 pAdMSC(i)不表达半乳糖-α1,3-半乳糖(Gal),但表达 hCD46,(ii)分化为软骨细胞、成骨细胞和脂肪细胞,(iii)表达干细胞标志物,(iv)在猪干扰素(IFN)-γ刺激前后,表达的猪白细胞抗原 I(SLAI)、猪白细胞抗原 II DR(SLAIIDR)和 CD80 水平低于 pAEC。hPBMC 对 GTKO/hCD46 pAdMSC 和 hAdMSC 刺激物的增殖反应相似,均明显低于 GTKO pAEC(P < 0.05)。GTKO/hCD46 pAdMSC 和 hAdMSC 同样抑制 hPBMC 对 GTKO pAEC 的增殖(P > 0.05)。GTKO/hCD46 pAdMSC 的上清液不能抑制人对 GTKO pAEC 的异种反应,该反应依赖于细胞间接触。
初步证据表明,基因修饰的 pAdMSC 可跨越异种障碍发挥作用,可能在细胞异种移植中发挥作用。